papillary thyroid cancer and glp-1 Glucagon-like-peptide-1 receptor expression in normal diseased human and pancreas GLP-1RA and thyroid cancer: New

Using both therapies simultaneously is physiologically rational if lab work confirms both suboptimal IGF-1 levels and elevated oxidative stress markers the mechanisms are complementary, not competitive

A higher content of total GSH was suggested to confer HT tolerance in T

Medication is not a standalone treatment

JACC Heart Fail 4(7):559566 Jorsal A, Kistorp C, Holmager P, Tougaard RS, Nielsen R, Hnselmann A, Nilsson B, Mller JE, Hjort J, Rasmussen J, Boesgaard TW, Schou M, Videbaek L, Gustafsson I, Flyvbjerg A, Wiggers H, Tarnow L (2017) Effect of liraglutide, a glucagon-like peptide-1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes (LIVE)-a multicentre, double-blind, randomised, placebo-controlled trial

Keep your doctor informed about your health condition and all the medicines you take to rule out any side effects